Speech Biomarkers in Huntington's Disease: A Longitudinal Follow-Up Study in Premanifest Mutation Carriers

J Huntingtons Dis. 2024;13(3):369-373. doi: 10.3233/JHD-240021.

Abstract

Speech alterations have been reported in manifest Huntington's disease (HD) and premanifest mutation carriers (preHD). The aim of our study was to explore these alterations in preHD and whether they can be used as biomarkers. 13 preHD mutation carriers performed reading task, sustained phonation task and syllable repetition tasks at baseline and after 21 months, as well as clinical examination and MRI. Syllable repetition capacity and self-chosen velocity of single syllable repetition differed significantly between time points. There were no changes in clinical ratings or MRI volumetry. Measurements of speech might be sensitive tools for monitoring subclinical changes in preHD.

Keywords: Huntington’s disease; dysarthria; phonation; prodromal biomarker; speech.

MeSH terms

  • Adult
  • Biomarkers
  • Female
  • Follow-Up Studies
  • Heterozygote*
  • Humans
  • Huntington Disease* / diagnostic imaging
  • Huntington Disease* / genetics
  • Huntington Disease* / physiopathology
  • Longitudinal Studies
  • Magnetic Resonance Imaging*
  • Male
  • Middle Aged
  • Mutation
  • Speech / physiology
  • Speech Disorders / etiology
  • Speech Disorders / genetics
  • Speech Disorders / physiopathology

Substances

  • Biomarkers